A--to expand the scope of the program by re-introducing the manufacture and distri
75N92018R0070
A RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) solicitation. AwardCast estimates what this specific solicitation will close for, before you bid.
75N92018R0070
solicitation
541715
NAICS
A
PSC
Women-Owned Small Business
set-aside
What's being bought
The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by re-introducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under
Comparable recent awards in RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| VEXTERRA GROUP LLC | $1000.0B | 589 | 2024-09-30 |
| A3 MISSIONS, LLC | $1000.0B | 579 | 2024-09-30 |
| R & K ENTERPRISE SOLUTIONS INC | $1000.0B | 579 | 2024-09-30 |
| IRON EAGLEX, INC. | $1000.0B | 584 | 2024-09-30 |
| DENOVO SOLUTIONS LLC | $1000.0B | 579 | 2024-09-30 |
Explore the market
Comparable awards ran from $1000.0B to $1000.0B. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.